Company intelligence / Profile preview

CSBio

Mountain View, California, United Statescsbio.com ↗

Ownership: Private
Employees: ~96
Development stage: Commercial

Overview

CSBio manufactures nonGMP and cGMP peptides from research to commercial scale. They have received FDA recommendation for approval for commercial production of exenatide API. Their facilities support clients from preclinical through market commercialization with regulatory support including DMF preparation.

Therapeutic areas: Other
Modalities: PeptidesPeptide APIs (Active Pharmaceutical Ingredients)Oligonucleotides (DNA/RNA synthesizers)Small molecule (as peptide APIs may include small peptides)
Industry: Contract Manufacturing Organization

Partnerships

NervGen Pharma (peptide manufacturing partnership)

Beyond the preview

Go deeper on CSBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CSBio.

Explore the full profile